Linked Data API

Show Search Form

Search Results

1140794
star this property registered interest false more like this
unstar this property date less than 2019-07-22more like thismore than 2019-07-22
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Medicine: Research more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what recent assessment he has made of UK capacity in translational research. more like this
star this property tabling member constituency Strangford remove filter
star this property tabling member printed
Jim Shannon more like this
star this property uin 280239 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-26more like thismore than 2019-07-26
star this property answer text <p>The Medical Research Council (MRC) covers basic through to translational research, with translational research and applied, clinical, public health and social care research funded by the Department via the National Institute for Health Research (NIHR).</p><p>The NIHR’s funding for research includes support for research infrastructure which is critically important in providing the resources, support and facilities that the National Health Service needs to conduct first-class research across the full pathway of discovery science to evaluation. The sustained, long-term funding to put in place through the NIHR infrastructure has been widely recognised as having transformed the health research environment in the United Kingdom. For example, there has been five-fold increase in early phase (phase I and phase II) trials since 2009 within the NIHR early translational research infrastructure in the NHS (2,842 phase I and phase II trials in 2017/18 compared to just 496 in 2009/10).</p><p>The MRC are also currently undertaking an evaluation of 10 years of MRC-funded translation research which is expected to be completed in September 2019.</p><p>The MRC and the NIHR also work in partnership through the Efficacy and Mechanism Evaluation programme which funds studies evaluating interventions with potential to make a step-change in the promotion of health, treatment of disease and improvement of rehabilitation or long-term care.</p><p> </p><p><strong> </strong></p><p><strong> </strong></p>
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-07-26T11:44:44.86Zmore like thismore than 2019-07-26T11:44:44.86Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1139372
star this property registered interest false more like this
unstar this property date less than 2019-07-16more like thismore than 2019-07-16
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Sophie Holman more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what response his Department has provided to the Prevention of Future Deaths report on the death of Sophie Holman. more like this
star this property tabling member constituency Strangford remove filter
star this property tabling member printed
Jim Shannon more like this
star this property uin 277727 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-23more like thismore than 2019-07-23
star this property answer text <p>The Department responded to the Prevention of Future Deaths Report issued by the Assistant Coroner for the Eastern Area of Greater London following the inquest into the death of Sophie Holman on 24 April 2019.</p><p>Publication of the Department’s response is a matter for the Chief Coroner as set out in Coroners (investigations) Regulations 2013.</p><p>The Government is committed to doing all it can to ensure the National Health Service learns from tragic, avoidable deaths and provides high quality, safe care for all patients. This is demonstrated by publication of the NHS Patient Safety Strategy on 2 July 2019. The strategy provides a framework for patient safety improvement over the next 10 years and sits alongside the NHS Long Term Plan.</p> more like this
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-07-23T16:04:26.67Zmore like thismore than 2019-07-23T16:04:26.67Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1139402
star this property registered interest false more like this
unstar this property date less than 2019-07-16more like thismore than 2019-07-16
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Medicine: Research more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what discussions he has had with the Chancellor of the Exchequer on the adequacy of funding for medical R&D in advance of the Spending Review. more like this
star this property tabling member constituency Strangford remove filter
star this property tabling member printed
Jim Shannon more like this
star this property uin 277741 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-25more like thismore than 2019-07-25
star this property answer text <p>My Rt. hon. Friend the Secretary of State for Health and Social Care met regularly with the former Chancellor (Rt. hon Philip Hammond MP) and other Cabinet colleagues to discuss a range of issues related to funding for medical research and development.</p><p>The Department’s National Institute for Health Research (NIHR) budget for 2019/20 is just over £1 billion and welcomes funding applications for research into any aspect of human health. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality. Information on individual projects funded by the NIHR can be found at the following link:</p><p><a href="https://www.journalslibrary.nihr.ac.uk/programmes/" target="_blank">https://www.journalslibrary.nihr.ac.uk/programmes/</a></p><p>The future of budgets outside of the NHS England resource settlement, including capital budgets for research and development, will be confirmed later this year at the Spending Review 2019.</p><p> </p>
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-07-25T14:20:17.517Zmore like thismore than 2019-07-25T14:20:17.517Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1137416
star this property registered interest false more like this
unstar this property date less than 2019-07-08more like thismore than 2019-07-08
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Accelerated Access Collaborative more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if he will list (a) the criteria and (b) the timelines for products to be considered in (i) the current and (ii) future review rounds of the Accelerated Access Collaborative. more like this
star this property tabling member constituency Strangford remove filter
star this property tabling member printed
Jim Shannon more like this
star this property uin 274540 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-15more like thismore than 2019-07-15
star this property answer text <p>In October 2018, the Accelerated Access Collaborative (AAC) announced it was supporting the uptake of 12 high performing products, with the potential to improve the lives of up to 500,000 patients per year and save the National Health Service £30 million per year in England. All the products currently being supported by the AAC have been recommended by the National Institute for Health and Care Excellence, and therefore evidence on clinical benefits and cost savings were considered as part of the process.</p><p>The AAC board met on 26 June and had a positive discussion about future products and expects to announce further products later this year.</p><p>The AAC will consider the following areas of interest when determining which products to support:</p><p>- evidence of clinical and cost effectiveness;</p><p>- addressing significant unmet need;</p><p>- application to large populations or high budget impact; and</p><p>- enabling a novel mode of action or enabling significant changes to the care pathway.</p><p> </p><p> </p><p> </p>
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-07-15T15:23:36.753Zmore like thismore than 2019-07-15T15:23:36.753Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1137417
star this property registered interest false more like this
unstar this property date less than 2019-07-08more like thismore than 2019-07-08
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Hospitals: Infectious Diseases more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what plans the Accelerated Access Collaborative has to prioritise products which help to control hospital-acquired infections. more like this
star this property tabling member constituency Strangford remove filter
star this property tabling member printed
Jim Shannon more like this
star this property uin 274541 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-15more like thismore than 2019-07-15
star this property answer text <p>The Accelerated Access Collaborative (AAC) is interested in identifying and supporting strategically important products that will have the biggest impact on patient health outcomes and/or the delivery of National Health Service services. This may include those which help control hospital-acquired infections.</p><p>The AAC has already had made significant progress towards getting the best innovations to patients quicker and at a better cost for the NHS.</p><p>Since 2018, NHS England has been supporting SecurAcath and Plus Sutures, products designed to reduce infection rates, on the Innovation and Technology Payment programme. SecurAcath is a device to secure catheters that reduces the infection risk for patients with a peripherally inserted central catheter and has benefited over 80,000 patients. Seven trusts with higher than 4% surgical site infection rates have adopted Plus Sutures, a triclosan coated suture, with more trusts to be supported this year.</p><p> </p><p><strong> </strong></p><p><strong> </strong></p>
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-07-15T15:26:22.27Zmore like thismore than 2019-07-15T15:26:22.27Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1137418
star this property registered interest false more like this
unstar this property date less than 2019-07-08more like thismore than 2019-07-08
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Accelerated Access Collaborative more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what criteria the Accelerated Access Collaborative uses in relation to decision-making on (a) medicines, (b) diagnostic tools and (c) digital services. more like this
star this property tabling member constituency Strangford remove filter
star this property tabling member printed
Jim Shannon more like this
star this property uin 274542 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-15more like thismore than 2019-07-15
star this property answer text <p>The Accelerated Access Collaborative (AAC) is interested in supporting the most strategically important products that will have the biggest impact on patient health outcomes and delivery of National Health Service services.</p><p>When selecting products, the AAC will consider the following irrespective of innovation type (i.e. medicines, diagnostic tools, and digital products):</p><p>- evidence of clinical and cost effectiveness;</p><p>- addressing significant unmet need;</p><p>- application to large populations or high budget impact; and</p><p>- enabling a novel mode of action or enabling significant changes to the care pathway.</p><p>Further information is available at the following link:</p><p><a href="https://www.nice.org.uk/aac" target="_blank">https://www.nice.org.uk/aac</a></p><p> </p><p> </p> more like this
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-07-15T15:33:03.587Zmore like thismore than 2019-07-15T15:33:03.587Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1134018
star this property registered interest false more like this
unstar this property date less than 2019-06-24more like thismore than 2019-06-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Accelerated Access Collaborative more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if he will list the (a) criteria and (b) timelines for products to be considered in (i) the current round and (ii) future review rounds of the Accelerated Access Collaborative route. more like this
star this property tabling member constituency Strangford remove filter
star this property tabling member printed
Jim Shannon more like this
star this property uin 268506 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-02more like thismore than 2019-07-02
star this property answer text <p>In October 2018, the Accelerated Access Collaborative (AAC) announced it was supporting the uptake of 12 high performing products, with the potential to improve the lives of up to 500,000 patients per year and save the National Health Service £30 million per year in England. All the products currently being supported by the AAC have been recommended by the National Institute for Health and Care Excellence, and therefore evidence on clinical benefits and cost savings were considered as part of the process.</p><p>The AAC board met on 26 June and had a positive discussion about future products and expects to announce further products later this year.</p><p>The AAC will consider the following areas of interest when determining which products to support:</p><p>- evidence of clinical and cost effectiveness;</p><p>- addressing significant unmet need;</p><p>- application to large populations or high budget impact; and</p><p>- enabling a novel mode of action or enabling significant changes to the care pathway.</p><p> </p><p> </p>
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-07-02T16:12:14.213Zmore like thismore than 2019-07-02T16:12:14.213Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1134019
star this property registered interest false more like this
unstar this property date less than 2019-06-24more like thismore than 2019-06-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Accelerated Access Collaborative more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how products selected by the Accelerated Access Collaborative will be funded. more like this
star this property tabling member constituency Strangford remove filter
star this property tabling member printed
Jim Shannon more like this
star this property uin 268507 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-02more like thismore than 2019-07-02
star this property answer text <p>As announced in the Life Sciences Sector Deal 2, up to £2 million of Pathway Transformation Funding has been made available to support the use and integration of product selected by the Accelerated Access Collaborative (AAC) into every day practice within the National Health Service. In addition, four of the seven technology areas currently receiving AAC support have been selected to be funded by NHS England through the Innovation and Technology Payment programme (ITP). The ITP aims to remove financial and procurement barriers to support the NHS to adopt innovative medical devices, diagnostics, and digital products.</p> more like this
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-07-02T16:07:33.677Zmore like thismore than 2019-07-02T16:07:33.677Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1134020
star this property registered interest false more like this
unstar this property date less than 2019-06-24more like thismore than 2019-06-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Accelerated Access Collaborative more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, whether all products considered by the Accelerated Access Collaborative will have to be cost-neutral to the NHS. more like this
star this property tabling member constituency Strangford remove filter
star this property tabling member printed
Jim Shannon more like this
star this property uin 268508 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-02more like thismore than 2019-07-02
star this property answer text <p>As it continues to drive forward the assessment and uptake of the best products for support, the Accelerated Access Collaborative (AAC) has been empowered to be flexible and pragmatic enough to identify truly game-changing innovations, that may not be cost-neutral in year, but are assessed by the National Institute for Health and Care Excellence to be both clinically and cost-effective. This will allow the AAC to identify products, or classes of products, that are most likely to significantly transform care in the National Health Service.</p> more like this
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-07-02T16:06:04.58Zmore like thismore than 2019-07-02T16:06:04.58Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1134021
star this property registered interest false more like this
unstar this property date less than 2019-06-24more like thismore than 2019-06-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Accelerated Access Collaborative more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what plans the Accelerated Access Collaborative has to prioritise products which help control hospital-acquired infections. more like this
star this property tabling member constituency Strangford remove filter
star this property tabling member printed
Jim Shannon more like this
star this property uin 268509 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-02more like thismore than 2019-07-02
star this property answer text <p>The Accelerated Access Collaborative (AAC) is interested in identifying and supporting strategically important products that will have the biggest impact on patient health outcomes and/or the delivery of NHS services. This may include those which help control hospital-acquired infections.</p><p>The AAC has already had made significant progress towards getting the best innovations to patients quicker and at a better cost for the National Health Service.</p><p>Since 2018, NHS England has been supporting SecurAcath and Plus Sutures, products designed to reduce infection rates, on the Innovation and Technology Payment programme. SecurAcath is a device to secure catheters that reduces the infection risk for patients with a peripherally inserted central catheter and has benefited over 80,000 patients. Seven trusts with higher than 4% surgical site infection rates have adopted Plus Sutures, a triclosan coated suture, with more trusts to be supported this year.</p><p> </p> more like this
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-07-02T16:12:48.417Zmore like thismore than 2019-07-02T16:12:48.417Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this